Sample Shipment details of PHARMAMETICS PRODUCTS A DIVISION OF MAX BIOCARE PTY LTD are given below.
Date | 04/Jan/2019 | Importer Name | Exporter Name |
HS Code | 30049098 | CôNG TY Cổ PHầN DượC PHẩM Hà TâY | PHARMAMETICS PRODUCTS A DIVISION OF MAX BIOCARE PTY LTD |
Quantity | 31773 | ||
Unit | kiện/hộp/bao/gói | ||
Value (US$) | 285957 | Port of Discharge | Port of Loading |
Unit Price (US$) | 9 | MELBOURNE - VI | Cat Lai Port (Ho Chi Minh) |
Origin Country | Australia | Product Description | Export country |
Payment Terms | TTR | Blood circulation medicine PM REMEM (GINKGO BILOBA LEAF EXTRACT DRY CONCENTRATE (50: 1) , 120MG). Box of 4 blisters x 15 tablets.Visa: VN-11788-11 Lot number 770319.NSX: 09/2018. HD: 09/2021. | Australia |
Import country | Viet Nam | ||
Name of Transportation | THANA BHUM/209N/9300142 |
Date | HS Code | Product Description | Quantity | Unit Price | Total Price | Importer Name | Exporter Name | Import country |
---|---|---|---|---|---|---|---|---|
04/Jan/2019 | 30049098 | Blood circulation medicine PM REMEM (GINKGO BILOBA LEAF EXTRACT DRY CONCENTRATE (50: 1) , 120MG). Box of 4 blisters x 15 tablets.Visa: VN-11788-11 Lot number 770319.NSX: 09/2018. HD: 09/2021. | 31773 | 9 | 285957 | View Importer | PHARMAMETICS PRODUCTS A DIVISION OF MAX BIOCARE PTY LTD | Australia |
04/Jan/2019 | 30049098 | Blood circulation medicine PM REMEM (GINKGO BILOBA LEAF EXTRACT DRY CONCENTRATE (50: 1) , 120MG). Box of 4 blisters x 15 tablets.Visa: VN-11788-11 Lot number 770319.NSX: 09/2018. HD: 09 / 2021.FOC | 1000 | 9 | 285957 | View Importer | PHARMAMETICS PRODUCTS A DIVISION OF MAX BIOCARE PTY LTD | Australia |
11/Jan/2019 | 30049098 | PM REMEM (GINKGO BILOBA LEAF EXTRACT DRY CONCENTRATE (50: 1) , 120MG) Box of 4 blisters x 15 tablets.Visa: VN-11788-11 Lot number 770323.NSX: October 2018. HD: 10/2021. | 32143 | 9 | 285957 | View Importer | PHARMAMETICS PRODUCTS A DIVISION OF MAX BIOCARE PTY LTD | Australia |
Our trade data is based on Actual shipment records, so View 360° of Vietnam's trade with the help of our Report.